Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Loos

Showing results (181-190 of 215) with videos related to

Pageof 22
Sort By:
Journal of Pediatric Surgery|December 8, 2016
Increased incidence of necrotizing enterocolitis in the Netherlands after implementation of the new Dutch guideline for active treatment in extremely preterm infants: Results from three academic referral centersFardou H Heida, Lisanne Stolwijk, Marie-Louise H J Loos, et al.
Clinical Pharmacology and Therapeutics|May 24, 2012
Effects of CYP induction by rifampicin on tamoxifen exposureL Binkhorst, T van Gelder, W J Loos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2007
Cigarette smoking and irinotecan treatment: pharmacokinetic interaction and effects on neutropeniaJessica M van der Bol, Ron H J Mathijssen, Walter J Loos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
Oral topotecan given once or twice daily for ten days: a phase I pharmacology study in adult patients with solid tumorsC J Gerrits, H Burris, J H Schellens, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase I and pharmacologic study of oral (PEG-1000) 9-aminocamptothecin in adult patients with solid tumorsM J de Jonge, C J Punt, A H Gelderblom, et al.
European Journal of Cancer (Oxford, England : 1990)|August 31, 2010
Early cessation of the clinical development of LiPlaCis, a liposomal cisplatin formulationMaja J A de Jonge, Marije Slingerland, Walter J Loos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 27, 2006
A phase I study assessing the safety and pharmacokinetics of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 with gemcitabine and cisplatin in patients with solid tumorsJ A Gietema, R Hoekstra, F Y F L de Vos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 2, 2012
A long-term prospective population pharmacokinetic study on imatinib plasma concentrations in GIST patientsKarel Eechoute, Martin N Fransson, An K Reyners, et al.
Nature Genetics|March 20, 2012
Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traitsJian Yang, Teresa Ferreira, Andrew P Morris, et al.
Obesity (Silver Spring, Md.)|July 22, 2014
Genome-wide association study of height-adjusted BMI in childhood identifies functional variant in ADCY3Evangelia Stergiakouli, Romy Gaillard, Jeremy M Tavaré, et al.
Pageof 22

Showing results (181-190 of 215) with videos related to

Sort By:
Pageof 22
Journal of Pediatric Surgery|December 8, 2016
Increased incidence of necrotizing enterocolitis in the Netherlands after implementation of the new Dutch guideline for active treatment in extremely preterm infants: Results from three academic referral centersFardou H Heida, Lisanne Stolwijk, Marie-Louise H J Loos, et al.
Clinical Pharmacology and Therapeutics|May 24, 2012
Effects of CYP induction by rifampicin on tamoxifen exposureL Binkhorst, T van Gelder, W J Loos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2007
Cigarette smoking and irinotecan treatment: pharmacokinetic interaction and effects on neutropeniaJessica M van der Bol, Ron H J Mathijssen, Walter J Loos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
Oral topotecan given once or twice daily for ten days: a phase I pharmacology study in adult patients with solid tumorsC J Gerrits, H Burris, J H Schellens, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase I and pharmacologic study of oral (PEG-1000) 9-aminocamptothecin in adult patients with solid tumorsM J de Jonge, C J Punt, A H Gelderblom, et al.
European Journal of Cancer (Oxford, England : 1990)|August 31, 2010
Early cessation of the clinical development of LiPlaCis, a liposomal cisplatin formulationMaja J A de Jonge, Marije Slingerland, Walter J Loos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 27, 2006
A phase I study assessing the safety and pharmacokinetics of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 with gemcitabine and cisplatin in patients with solid tumorsJ A Gietema, R Hoekstra, F Y F L de Vos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 2, 2012
A long-term prospective population pharmacokinetic study on imatinib plasma concentrations in GIST patientsKarel Eechoute, Martin N Fransson, An K Reyners, et al.
Nature Genetics|March 20, 2012
Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traitsJian Yang, Teresa Ferreira, Andrew P Morris, et al.
Obesity (Silver Spring, Md.)|July 22, 2014
Genome-wide association study of height-adjusted BMI in childhood identifies functional variant in ADCY3Evangelia Stergiakouli, Romy Gaillard, Jeremy M Tavaré, et al.
Pageof 22